Rapid electrochemical detection on a mobile phone.

Area of Science:

• Biotechnology
• Mobile Health (mHealth)
• Biosensing Technology

Background:

• Point-of-care diagnostics are crucial for timely disease management, especially in resource-limited settings.
• Existing diagnostic tools often lack portability, speed, and quantitative accuracy.
• Mobile technology offers a promising platform for developing accessible diagnostic solutions.

Purpose of the Study:

• To develop and validate a compact mobile phone platform for rapid, quantitative biomolecular detection.
• To assess the platform's performance using a malaria biomarker (Plasmodium falciparum histidine-rich protein 2).
• To evaluate the potential of this technology for point-of-care diagnostics and other applications.

Main Methods:

• Integration of a mobile phone with an embedded signal processing circuit and disposable microfluidic chips.
• Utilizing capillary flow for sample handling and automated data analysis displayed on the phone.
• Quantification of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) in human serum.

Main Results:

• The mobile phone platform achieved a lower limit of detection of 16 ng mL(-1) for PfHRP2 in human serum.
• The detection process is rapid, completing each measurement in 15 minutes with simple loading steps.
• The system provides immediate results displayed on the phone and automatic data saving.

Conclusions:

• The developed mobile phone platform is a compact, high-performance diagnostic tool.
• It offers immense potential as a widely accessible, point-of-care diagnostic platform, particularly for remote areas.
• The technology is applicable to global healthcare, food safety, environmental monitoring, and biosecurity.